Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysisCapsule Summary

Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysisCapsule Summary

Background: Little is known about the effectiveness and drug survival associated with apremilast under real-world conditions. Objective: To investigate the influence of patient and disease characteristics on drug survival associated with apremilast and to elucidate clinical effectiveness with regard...

Full description

Bibliographic Details
Main Authors: Thomas Graier, MD, Wolfgang Weger, MD, Paul-Gunther Sator, MD, Wolfgang Salmhofer, MD, Barbara Gruber, MD, Constanze Jonak, MD, Claudia Kölli, MD, Martina Schütz-Bergmayr, MD, Igor Vujic, MD, Gudrun Ratzinger, MD, Nina Häring, MD, Clemens Painsi, MD, PhD, Knut Prillinger, MD, Alexander Mlynek, MD, Hans Skvara, MD, Hannes Trattner, MD, Adrian Tanew, MD, Roland Lichem, MD, Christina Ellersdorfer, MD, Franz Legat, MD, Alexandra Gruber-Wackernagel, MD, Angelika Hofer, MD, Erich Schmiedberger, MSc, Wolfram Hoetzenecker, MD, PhD, Robert Müllegger, MD, Werner Saxinger, MD, Franz Quehenberger, PhD, Peter Wolf, MD
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:JAAD International
Subjects:
apremilast
drug survival
psoriasis
Online Access:http://www.sciencedirect.com/science/article/pii/S2666328720300717

Internet

http://www.sciencedirect.com/science/article/pii/S2666328720300717

Similar Items